DRUGS
The determination of the three-dimensional structure of proteins, that is, the position of each of their atoms and their interactions, allows the development of new technologies for drug discovery. From the moment a protein is identified as the therapeutic target, the structural study with synchrotron light can show how a drug binds to that molecule, guide modifications to improve that drug binding, or even suggest which modifications in the molecular structure of the drug can be done without affecting their binding abilities in the protein.